High STAT4 expression correlates with poor prognosis in acute myeloid leukemia and facilitates disease progression by upregulating VEGFA expression

被引:3
作者
Li, Aohang [1 ]
Wu, Jingxuan [2 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Clin Lab Ctr, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Res Ward, Beijing, Peoples R China
来源
OPEN MEDICINE | 2024年 / 19卷 / 01期
关键词
acute myeloid leukemia; poor prognosis; STAT4; VEGFA; apoptosis; angiogenesis; SIGNAL TRANSDUCER; ACTIVATOR; ANGIOGENESIS; RISK;
D O I
10.1515/med-2023-0840
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study is to explore the mechanism of transcription-4 (STAT4) in acute myeloid leukemia (AML). STAT4 level in AML bone marrow samples/cells was analyzed using bioinformatics and quantitative real-time PCR. The correlation between high STAT4 expression and the prognosis of AML patients was analyzed. The viability, apoptosis, and angiogenesis of AML cells were detected. The levels of STAT4, vascular endothelial growth factor A (VEGFA), and apoptosis-related proteins (Bcl-2 and Bax) in transfected AML cells were examined. STAT4 level was upregulated in AML. STAT4 silencing decreased the viability and angiogenesis, yet increased the apoptosis of AML cells, while overexpressed STAT4 did conversely. VEGFA silencing counteracted the impacts of overexpressed STAT4 upon promoting viability and angiogenesis as well as repressing the apoptosis of AML cells. High STAT4 expression was correlated with poor prognosis of AML patients and facilitated disease progression via upregulating VEGFA expression.
引用
收藏
页数:13
相关论文
共 44 条
[1]   Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS/p53/ BAI1 signaling pathway [J].
Cao, Jinghua ;
Liu, Xiaohua ;
Yang, Yang ;
Wei, Bo ;
Li, Qianming ;
Mao, Guanquan ;
He, Yajun ;
Li, Yuanyuan ;
Zheng, Lingyun ;
Zhang, Qianqian ;
Li, Jiangchao ;
Wang, Lijing ;
Qi, Cuiling .
ANGIOGENESIS, 2020, 23 (03) :325-338
[2]   Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia [J].
Celik, Haydar ;
Lindblad, Katherine E. ;
Popescu, Bogdan ;
Gui, Gege ;
Goswami, Meghali ;
Valdez, Janet ;
DeStefano, Christin ;
Lai, Catherine ;
Thompson, Julie ;
Ghannam, Jack Y. ;
Fantoni, Giovanna ;
Biancotto, Angelique ;
Candia, Julian ;
Cheung, Foo ;
Sukumar, Gauthaman ;
Dalgard, Clifton L. ;
Smith, Richard H. ;
Larochelle, Andre ;
Dillon, Laura W. ;
Hourigan, Christopher S. .
BLOOD ADVANCES, 2020, 4 (02) :367-379
[3]   An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis [J].
Cheranov, Sergey Y. ;
Karpurapu, Manjula ;
Wang, Dong ;
Zhang, Baolin ;
Venema, Richard C. ;
Rao, Gadiparthi N. .
BLOOD, 2008, 111 (12) :5581-5591
[4]  
Dewson G, 2016, METHODS MOL BIOL, V1491, P185, DOI 10.1007/978-1-4939-3581-9_14
[5]   Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy [J].
Elgarten, Caitlin W. ;
Aplenc, Richard .
CURRENT OPINION IN PEDIATRICS, 2020, 32 (01) :57-66
[6]   Acute myeloid leukemia: 2019 update on risk-stratification and management [J].
Estey, Elihu H. .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (10) :1267-1291
[7]   Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue [J].
Fatima, L. A. ;
Campello, R. S. ;
Santos, R. de Souza ;
Freitas, H. S. ;
Frank, A. P. ;
Machado, U. F. ;
Clegg, D. J. .
SCIENTIFIC REPORTS, 2017, 7
[8]   Risk of Leukemia Associated with Protracted Low-Dose Radiation Exposure: Updated Results from the National Registry for Radiation Workers Study [J].
Gillies, Michael ;
Haylock, Richard ;
Hunter, Nezhat ;
Zhang, Wei .
RADIATION RESEARCH, 2019, 192 (05) :527-537
[9]   Gemtuzumab ozogamicin in acute myeloid leukemia [J].
Godwin, C. D. ;
Gale, R. P. ;
Walter, R. B. .
LEUKEMIA, 2017, 31 (09) :1855-1868
[10]   Dihydromyricetin sensitizes human acute myeloid leukemia cells to retinoic acid-induced myeloid differentiation by activating STAT1 [J].
He, Ming-hui ;
Zhang, Qiang ;
Shu, Gang ;
Lin, Ju-chun ;
Zhao, Ling ;
Liang, Xiao-xia ;
Yin, Lizi ;
Shi, Fei ;
Fu, Hua-lin ;
Yuan, Zhi-xiang .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (02) :1702-1707